IL10 and COVID-19: Furthermore, we identified a unique signature of pathogenesis in patients with COVID-19, characterized by high levels of IL-10 production in the lungs and intestine, which might inhibit HLA-DR expression on macrophages or DCs, and TNF-α overproduction in the lungs, intestines, and other damaged tissues.